Liyu Su
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Randomized phase-II trial of surufatinib plus FOLFOX/FOLFIRI versus FOLFOXIRI as second-line therapy for metastatic colorectal cancer.
Journal: Annals of medicine
Published: July 09, 2026
Intravenous Patient-Controlled Analgesia Versus Oral Opioids to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase III Trial.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 26, 2025
Erythrocyte lifespan for predicting moderate and severe anemia in advanced gastric cancer patients post-anti-tumor therapeutics: a prospective study.
Journal: BMC cancer
Published: March 03, 2025
Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II Trial.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 06, 2022
Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer.
Journal: Frontiers in oncology
Published: January 07, 2022
A kinase-interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients.
Journal: Journal of clinical laboratory analysis
Published: February 25, 2020
Long-term impact of prognostic nutritional index in cervical esophageal squamous cell carcinoma patients undergoing definitive radiotherapy.
Journal: Annals of translational medicine
Published: June 07, 2019
Postoperative chemoradiotherapy is superior to postoperative chemotherapy alone in squamous cell lung cancer patients with limited N2 lymph node metastasis.
Journal: BMC cancer
Published: March 07, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026